Not-for-pro-fit drugs - no longer an oxymoron?

被引：4

作者：

Sharp, D ^{[1
]}

机构：

[1] Lancet, London NW1 7BY, England

来源：

LANCET | 2004年 / 364卷 / 9444期

关键词：

D O I：

10.1016/S0140-6736(04)17291-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1472 / 1474

页数：3

共 7 条

[1]

*B M GAT FDN, 2004, ANN REP 2003 RESP NE

[2]

*MED MAL VENT, 2004, CUR MAL TOG ANN REP

[3] Micro(mechanical) phones - Integrating microphones and speakers on a chip could be a big deal for MEMS [J].

Stix, G .

SCIENTIFIC AMERICAN, 2004, 290 (02) :28-+

[4] Drug development for neglected diseases: a deficient market and a public-health policy failure [J].

Trouiller, P ;

Olliaro, P ;

Torreele, E ;

Orbinski, J ;

Laing, R ;

Ford, N .

LANCET, 2002, 359 (9324) :2188-2194

[5] Identification of an antimalarial synthetic trioxolane drug development candidate [J].

Vennerstrom, JL ;

Arbe-Barnes, S ;

Brun, R ;

Charman, SA ;

Chiu, FCK ;

Chollet, J ;

Dong, YX ;

Dorn, A ;

Hunziker, D ;

Matile, H ;

McIntosh, K ;

Padmanilayam, M ;

Tomas, JS ;

Scheurer, C ;

Scorneaux, B ;

Tang, YQ ;

Urwyler, H ;

Wittlin, S ;

Charman, WN .

NATURE, 2004, 430 (7002) :900-904

[6]

Wheeler C, 2001, B WORLD HEALTH ORGAN, V79, P728

[7]

Widdus R., 2004, COMBATING DIS ASS PO

← 1 →